Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Non Operating Income (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Non Operating Income for 3 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 188.6% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 million, a 211.42% increase, with the full-year FY2025 number at $5.9 million, up 211.42% from a year prior.
  • Non Operating Income was $2.5 million for Q4 2025 at Artiva Biotherapeutics, up from -$3000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $3.4 million in Q2 2025 to a low of -$4000.0 in Q1 2025.
  • A 3-year average of $990000.0 and a median of $505000.0 in 2024 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 15450.0% in 2025; the steepest drop was 102.72% in 2025.
  • Artiva Biotherapeutics' Non Operating Income stood at $44000.0 in 2023, then skyrocketed by 1893.18% to $877000.0 in 2024, then skyrocketed by 188.6% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for ARTV's Non Operating Income are $2.5 million (Q4 2025), -$3000.0 (Q3 2025), and $3.4 million (Q2 2025).